SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2qmm'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1A4L_C_DCFC1353_2 (ADENOSINE DEAMINASE)	2qmm	UPF0217 PROTEIN AF_1056 (Archaeoglobus fulgidus)	4 / 5	LEU A 149 LEU A 147 LEU A 212 GLY A 204	None	0.94A	1a4lC-2qmmA: undetectable	1a4lC-2qmmA: 20.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FSL_A_NIOA145_1 (LEGHEMOGLOBIN A)	2qmm	UPF0217 PROTEIN AF_1056 (Archaeoglobus fulgidus)	4 / 8	PHE A 239 ILE A 219 HIS A 282 LEU A 283	None	0.89A	1fslA-2qmmA: undetectable	1fslA-2qmmA: 20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1X7P_A_SAMA301_0 (RRNA METHYLTRANSFERASE)	2qmm	UPF0217 PROTEIN AF_1056 (Archaeoglobus fulgidus)	5 / 11	GLY A 242 GLY A 246 SER A 269 LEU A 270 ALA A 272	SAM A 301 (-3.6A) SAM A 301 (-3.3A) SAM A 301 (-4.1A) SAM A 301 (-4.5A) SAM A 301 ( 4.0A)	0.58A	1x7pA-2qmmA: 10.0 1x7pB-2qmmA: 10.5	1x7pA-2qmmA: 23.13 1x7pB-2qmmA: 23.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2QMM_A_SAMA301_0 (UPF0217 PROTEIN AF_1056)	2qmm	UPF0217 PROTEIN AF_1056 (Archaeoglobus fulgidus)	9 / 9	LEU A 221 GLU A 223 ILE A 241 GLY A 242 GLY A 246 SER A 264 SER A 266 LEU A 270 CYH A 275	SAM A 301 (-4.3A) SAM A 301 (-3.5A) SAM A 301 ( 4.8A) SAM A 301 (-3.6A) SAM A 301 (-3.3A) SAM A 301 (-3.4A) SAM A 301 (-4.2A) SAM A 301 (-4.5A) SAM A 301 (-3.1A)	0.02A	2qmmA-2qmmA: 41.2	2qmmA-2qmmA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2QMM_B_SAMB301_0 (UPF0217 PROTEIN AF_1056)	2qmm	UPF0217 PROTEIN AF_1056 (Archaeoglobus fulgidus)	10 / 11	LEU A 221 GLU A 223 ILE A 241 GLY A 242 GLY A 246 SER A 264 LEU A 265 SER A 266 LEU A 270 CYH A 275	SAM A 301 (-4.3A) SAM A 301 (-3.5A) SAM A 301 ( 4.8A) SAM A 301 (-3.6A) SAM A 301 (-3.3A) SAM A 301 (-3.4A) SAM A 301 (-4.4A) SAM A 301 (-4.2A) SAM A 301 (-4.5A) SAM A 301 (-3.1A)	0.20A	2qmmA-2qmmA: 41.2 2qmmB-2qmmA: 39.0	2qmmA-2qmmA: 100.00 2qmmB-2qmmA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2QMM_B_SAMB301_0 (UPF0217 PROTEIN AF_1056)	2qmm	UPF0217 PROTEIN AF_1056 (Archaeoglobus fulgidus)	6 / 11	SER A 269 ILE A 241 GLY A 242 GLY A 246 LEU A 270 CYH A 275	SAM A 301 (-4.1A) SAM A 301 ( 4.8A) SAM A 301 (-3.6A) SAM A 301 (-3.3A) SAM A 301 (-4.5A) SAM A 301 (-3.1A)	1.18A	2qmmA-2qmmA: 41.2 2qmmB-2qmmA: 39.0	2qmmA-2qmmA: 100.00 2qmmB-2qmmA: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V3K_A_SAMA1254_0 (ESSENTIAL FOR MITOTIC GROWTH 1)	2qmm	UPF0217 PROTEIN AF_1056 (Archaeoglobus fulgidus)	5 / 10	LEU A 221 GLY A 242 LEU A 265 SER A 266 LEU A 270	SAM A 301 (-4.3A) SAM A 301 (-3.6A) SAM A 301 (-4.4A) SAM A 301 (-4.2A) SAM A 301 (-4.5A)	0.54A	2v3kA-2qmmA: 14.7	2v3kA-2qmmA: 26.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Z97_A_CAMA422_0 (CYTOCHROME P450-CAM)	2qmm	UPF0217 PROTEIN AF_1056 (Archaeoglobus fulgidus)	4 / 6	LEU A 149 VAL A 101 VAL A 254 VAL A 255	None	1.00A	2z97A-2qmmA: undetectable	2z97A-2qmmA: 18.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3AI9_X_SAMX501_0 (UPF0217 PROTEIN MJ1640)	2qmm	UPF0217 PROTEIN AF_1056 (Archaeoglobus fulgidus)	8 / 9	LEU A 221 ILE A 241 GLY A 242 SER A 264 LEU A 265 SER A 266 LEU A 270 CYH A 275	SAM A 301 (-4.3A) SAM A 301 ( 4.8A) SAM A 301 (-3.6A) SAM A 301 (-3.4A) SAM A 301 (-4.4A) SAM A 301 (-4.2A) SAM A 301 (-4.5A) SAM A 301 (-3.1A)	0.36A	3ai9X-2qmmA: 31.2	3ai9X-2qmmA: 43.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3AIA_A_SAMA206_0 (UPF0217 PROTEIN MJ1640)	2qmm	UPF0217 PROTEIN AF_1056 (Archaeoglobus fulgidus)	5 / 6	LEU A 221 GLY A 242 LEU A 265 SER A 266 CYH A 275	SAM A 301 (-4.3A) SAM A 301 (-3.6A) SAM A 301 (-4.4A) SAM A 301 (-4.2A) SAM A 301 (-3.1A)	0.33A	3aiaA-2qmmA: 31.8	3aiaA-2qmmA: 44.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3J6P_B_TA1B502_1 (TUBULIN BETA CHAIN)	2qmm	UPF0217 PROTEIN AF_1056 (Archaeoglobus fulgidus)	5 / 12	VAL A 142 ASP A 141 ARG A 285 PRO A 237 LEU A 233	None	1.28A	3j6pB-2qmmA: undetectable	3j6pB-2qmmA: 17.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NK7_B_SAMB770_0 (23S RRNA METHYLTRANSFERASE)	2qmm	UPF0217 PROTEIN AF_1056 (Archaeoglobus fulgidus)	5 / 12	LEU A 221 GLY A 242 GLY A 246 SER A 269 LEU A 270	SAM A 301 (-4.3A) SAM A 301 (-3.6A) SAM A 301 (-3.3A) SAM A 301 (-4.1A) SAM A 301 (-4.5A)	0.94A	3nk7B-2qmmA: 10.7	3nk7B-2qmmA: 21.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FAK_A_SAMA201_0 (RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE H)	2qmm	UPF0217 PROTEIN AF_1056 (Archaeoglobus fulgidus)	5 / 10	LEU A 221 ILE A 241 GLY A 242 GLY A 246 SER A 266	SAM A 301 (-4.3A) SAM A 301 ( 4.8A) SAM A 301 (-3.6A) SAM A 301 (-3.3A) SAM A 301 (-4.2A)	0.69A	4fakA-2qmmA: 6.9	4fakA-2qmmA: 23.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XUM_A_IMNA502_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	2qmm	UPF0217 PROTEIN AF_1056 (Archaeoglobus fulgidus)	4 / 7	GLU A 164 ILE A 160 ARG A 139 ILE A 138	None	0.48A	4xumA-2qmmA: undetectable	4xumA-2qmmA: 23.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5O96_B_SAMB501_0 (RIBOSOMAL RNA SMALL SUBUNIT METHYLTRANSFERASE E)	2qmm	UPF0217 PROTEIN AF_1056 (Archaeoglobus fulgidus)	6 / 9	LEU A 221 ILE A 241 GLY A 242 GLY A 246 LEU A 265 LEU A 270	SAM A 301 (-4.3A) SAM A 301 ( 4.8A) SAM A 301 (-3.6A) SAM A 301 (-3.3A) SAM A 301 (-4.4A) SAM A 301 (-4.5A)	0.73A	5o96A-2qmmA: 10.9 5o96B-2qmmA: 11.2	5o96A-2qmmA: 25.40 5o96B-2qmmA: 25.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5O96_G_SAMG501_0 (RIBOSOMAL RNA SMALL SUBUNIT METHYLTRANSFERASE E)	2qmm	UPF0217 PROTEIN AF_1056 (Archaeoglobus fulgidus)	5 / 11	LEU A 221 GLY A 242 GLY A 246 LEU A 265 GLU A 273	SAM A 301 (-4.3A) SAM A 301 (-3.6A) SAM A 301 (-3.3A) SAM A 301 (-4.4A) None	0.77A	5o96G-2qmmA: 11.2	5o96G-2qmmA: 25.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5O96_G_SAMG501_0 (RIBOSOMAL RNA SMALL SUBUNIT METHYLTRANSFERASE E)	2qmm	UPF0217 PROTEIN AF_1056 (Archaeoglobus fulgidus)	5 / 11	LEU A 221 GLY A 242 GLY A 246 SER A 264 LEU A 265	SAM A 301 (-4.3A) SAM A 301 (-3.6A) SAM A 301 (-3.3A) SAM A 301 (-3.4A) SAM A 301 (-4.4A)	1.03A	5o96G-2qmmA: 11.2	5o96G-2qmmA: 25.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TWJ_A_SAMA201_0 (RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE H)	2qmm	UPF0217 PROTEIN AF_1056 (Archaeoglobus fulgidus)	7 / 12	LEU A 221 ILE A 241 GLY A 242 GLY A 246 SER A 264 LEU A 265 SER A 266	SAM A 301 (-4.3A) SAM A 301 ( 4.8A) SAM A 301 (-3.6A) SAM A 301 (-3.3A) SAM A 301 (-3.4A) SAM A 301 (-4.4A) SAM A 301 (-4.2A)	0.61A	5twjA-2qmmA: 6.6	5twjA-2qmmA: 25.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TWJ_A_SAMA201_0 (RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE H)	2qmm	UPF0217 PROTEIN AF_1056 (Archaeoglobus fulgidus)	7 / 12	LEU A 221 ILE A 241 GLY A 242 GLY A 246 SER A 264 SER A 266 LEU A 270	SAM A 301 (-4.3A) SAM A 301 ( 4.8A) SAM A 301 (-3.6A) SAM A 301 (-3.3A) SAM A 301 (-3.4A) SAM A 301 (-4.2A) SAM A 301 (-4.5A)	0.46A	5twjA-2qmmA: 6.6	5twjA-2qmmA: 25.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TWJ_B_SAMB201_0 (RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE H)	2qmm	UPF0217 PROTEIN AF_1056 (Archaeoglobus fulgidus)	6 / 10	LEU A 221 ILE A 241 GLY A 242 GLY A 246 LEU A 265 SER A 266	SAM A 301 (-4.3A) SAM A 301 ( 4.8A) SAM A 301 (-3.6A) SAM A 301 (-3.3A) SAM A 301 (-4.4A) SAM A 301 (-4.2A)	0.66A	5twjB-2qmmA: 6.4	5twjB-2qmmA: 25.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TWJ_B_SAMB201_0 (RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE H)	2qmm	UPF0217 PROTEIN AF_1056 (Archaeoglobus fulgidus)	6 / 10	LEU A 221 ILE A 241 GLY A 242 GLY A 246 SER A 266 LEU A 270	SAM A 301 (-4.3A) SAM A 301 ( 4.8A) SAM A 301 (-3.6A) SAM A 301 (-3.3A) SAM A 301 (-4.2A) SAM A 301 (-4.5A)	0.50A	5twjB-2qmmA: 6.4	5twjB-2qmmA: 25.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TWJ_C_SAMC201_0 (RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE H)	2qmm	UPF0217 PROTEIN AF_1056 (Archaeoglobus fulgidus)	6 / 12	LEU A 221 ILE A 241 GLY A 242 SER A 264 LEU A 265 SER A 266	SAM A 301 (-4.3A) SAM A 301 ( 4.8A) SAM A 301 (-3.6A) SAM A 301 (-3.4A) SAM A 301 (-4.4A) SAM A 301 (-4.2A)	0.56A	5twjC-2qmmA: 7.4	5twjC-2qmmA: 25.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TWJ_C_SAMC201_0 (RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE H)	2qmm	UPF0217 PROTEIN AF_1056 (Archaeoglobus fulgidus)	6 / 12	LEU A 221 ILE A 241 GLY A 242 SER A 264 SER A 266 LEU A 270	SAM A 301 (-4.3A) SAM A 301 ( 4.8A) SAM A 301 (-3.6A) SAM A 301 (-3.4A) SAM A 301 (-4.2A) SAM A 301 (-4.5A)	0.46A	5twjC-2qmmA: 7.4	5twjC-2qmmA: 25.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5TWJ_D_SAMD201_0 (RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE H)	2qmm	UPF0217 PROTEIN AF_1056 (Archaeoglobus fulgidus)	7 / 11	LEU A 221 ILE A 241 GLY A 242 GLY A 246 LEU A 265 SER A 266 LEU A 270	SAM A 301 (-4.3A) SAM A 301 ( 4.8A) SAM A 301 (-3.6A) SAM A 301 (-3.3A) SAM A 301 (-4.4A) SAM A 301 (-4.2A) SAM A 301 (-4.5A)	0.66A	5twjD-2qmmA: 7.4	5twjD-2qmmA: 25.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZHM_B_SAMB301_1 (TRNA (GUANINE-N(1)-)-METH YLTRANSFERASE)	2qmm	UPF0217 PROTEIN AF_1056 (Archaeoglobus fulgidus)	5 / 12	LEU A 221 GLY A 242 GLY A 246 SER A 264 LEU A 270	SAM A 301 (-4.3A) SAM A 301 (-3.6A) SAM A 301 (-3.3A) SAM A 301 (-3.4A) SAM A 301 (-4.5A)	0.78A	5zhmB-2qmmA: 8.4	5zhmB-2qmmA: 23.00

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1A4L_C_DCFC1353_2","ADENOSINE DEAMINASE","2qmm","UPF0217 PROTEIN AF_1056","Archaeoglobus fulgidus",4,"LEU A 149;LEU A 147;LEU A 212;GLY A 204","None","0.94A","1a4lC-2qmmA:undetectable","1a4lC-2qmmA:20.06"],["1FSL_A_NIOA145_1","LEGHEMOGLOBIN A","2qmm","UPF0217 PROTEIN AF_1056","Archaeoglobus fulgidus",4,"PHE A 239;ILE A 219;HIS A 282;LEU A 283","None","0.89A","1fslA-2qmmA:undetectable","1fslA-2qmmA:20.69"],["1X7P_A_SAMA301_0","RRNA METHYLTRANSFERASE","2qmm","UPF0217 PROTEIN AF_1056","Archaeoglobus fulgidus",5,"GLY A 242;GLY A 246;SER A 269;LEU A 270;ALA A 272","SAM A 301 (-3.6A);SAM A 301 (-3.3A);SAM A 301 (-4.1A);SAM A 301 (-4.5A);SAM A 301 ( 4.0A)","0.58A","1x7pA-2qmmA:10.0;1x7pB-2qmmA:10.5","1x7pA-2qmmA:23.13;1x7pB-2qmmA:23.13"],["2QMM_A_SAMA301_0","UPF0217 PROTEIN AF_1056","2qmm","UPF0217 PROTEIN AF_1056","Archaeoglobus fulgidus",9,"LEU A 221;GLU A 223;ILE A 241;GLY A 242;GLY A 246;SER A 264;SER A 266;LEU A 270;CYH A 275","SAM A 301 (-4.3A);SAM A 301 (-3.5A);SAM A 301 ( 4.8A);SAM A 301 (-3.6A);SAM A 301 (-3.3A);SAM A 301 (-3.4A);SAM A 301 (-4.2A);SAM A 301 (-4.5A);SAM A 301 (-3.1A)","0.02A","2qmmA-2qmmA:41.2","2qmmA-2qmmA:100.00"],["2QMM_B_SAMB301_0","UPF0217 PROTEIN AF_1056","2qmm","UPF0217 PROTEIN AF_1056","Archaeoglobus fulgidus",10,"LEU A 221;GLU A 223;ILE A 241;GLY A 242;GLY A 246;SER A 264;LEU A 265;SER A 266;LEU A 270;CYH A 275","SAM A 301 (-4.3A);SAM A 301 (-3.5A);SAM A 301 ( 4.8A);SAM A 301 (-3.6A);SAM A 301 (-3.3A);SAM A 301 (-3.4A);SAM A 301 (-4.4A);SAM A 301 (-4.2A);SAM A 301 (-4.5A);SAM A 301 (-3.1A)","0.20A","2qmmA-2qmmA:41.2;2qmmB-2qmmA:39.0","2qmmA-2qmmA:100.00;2qmmB-2qmmA:100.00"],["2QMM_B_SAMB301_0","UPF0217 PROTEIN AF_1056","2qmm","UPF0217 PROTEIN AF_1056","Archaeoglobus fulgidus",6,"SER A 269;ILE A 241;GLY A 242;GLY A 246;LEU A 270;CYH A 275","SAM A 301 (-4.1A);SAM A 301 ( 4.8A);SAM A 301 (-3.6A);SAM A 301 (-3.3A);SAM A 301 (-4.5A);SAM A 301 (-3.1A)","1.18A","2qmmA-2qmmA:41.2;2qmmB-2qmmA:39.0","2qmmA-2qmmA:100.00;2qmmB-2qmmA:100.00"],["2V3K_A_SAMA1254_0","ESSENTIAL FOR MITOTIC GROWTH 1","2qmm","UPF0217 PROTEIN AF_1056","Archaeoglobus fulgidus",5,"LEU A 221;GLY A 242;LEU A 265;SER A 266;LEU A 270","SAM A 301 (-4.3A);SAM A 301 (-3.6A);SAM A 301 (-4.4A);SAM A 301 (-4.2A);SAM A 301 (-4.5A)","0.54A","2v3kA-2qmmA:14.7","2v3kA-2qmmA:26.32"],["2Z97_A_CAMA422_0","CYTOCHROME P450-CAM","2qmm","UPF0217 PROTEIN AF_1056","Archaeoglobus fulgidus",4,"LEU A 149;VAL A 101;VAL A 254;VAL A 255","None","1.00A","2z97A-2qmmA:undetectable","2z97A-2qmmA:18.87"],["3AI9_X_SAMX501_0","UPF0217 PROTEIN MJ1640","2qmm","UPF0217 PROTEIN AF_1056","Archaeoglobus fulgidus",8,"LEU A 221;ILE A 241;GLY A 242;SER A 264;LEU A 265;SER A 266;LEU A 270;CYH A 275","SAM A 301 (-4.3A);SAM A 301 ( 4.8A);SAM A 301 (-3.6A);SAM A 301 (-3.4A);SAM A 301 (-4.4A);SAM A 301 (-4.2A);SAM A 301 (-4.5A);SAM A 301 (-3.1A)","0.36A","3ai9X-2qmmA:31.2","3ai9X-2qmmA:43.81"],["3AIA_A_SAMA206_0","UPF0217 PROTEIN MJ1640","2qmm","UPF0217 PROTEIN AF_1056","Archaeoglobus fulgidus",5,"LEU A 221;GLY A 242;LEU A 265;SER A 266;CYH A 275","SAM A 301 (-4.3A);SAM A 301 (-3.6A);SAM A 301 (-4.4A);SAM A 301 (-4.2A);SAM A 301 (-3.1A)","0.33A","3aiaA-2qmmA:31.8","3aiaA-2qmmA:44.29"],["3J6P_B_TA1B502_1","TUBULIN BETA CHAIN","2qmm","UPF0217 PROTEIN AF_1056","Archaeoglobus fulgidus",5,"VAL A 142;ASP A 141;ARG A 285;PRO A 237;LEU A 233","None","1.28A","3j6pB-2qmmA:undetectable","3j6pB-2qmmA:17.53"],["3NK7_B_SAMB770_0","23S RRNA METHYLTRANSFERASE","2qmm","UPF0217 PROTEIN AF_1056","Archaeoglobus fulgidus",5,"LEU A 221;GLY A 242;GLY A 246;SER A 269;LEU A 270","SAM A 301 (-4.3A);SAM A 301 (-3.6A);SAM A 301 (-3.3A);SAM A 301 (-4.1A);SAM A 301 (-4.5A)","0.94A","3nk7B-2qmmA:10.7","3nk7B-2qmmA:21.35"],["4FAK_A_SAMA201_0","RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE H","2qmm","UPF0217 PROTEIN AF_1056","Archaeoglobus fulgidus",5,"LEU A 221;ILE A 241;GLY A 242;GLY A 246;SER A 266","SAM A 301 (-4.3A);SAM A 301 ( 4.8A);SAM A 301 (-3.6A);SAM A 301 (-3.3A);SAM A 301 (-4.2A)","0.69A","4fakA-2qmmA:6.9","4fakA-2qmmA:23.94"],["4XUM_A_IMNA502_1","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","2qmm","UPF0217 PROTEIN AF_1056","Archaeoglobus fulgidus",4,"GLU A 164;ILE A 160;ARG A 139;ILE A 138","None","0.48A","4xumA-2qmmA:undetectable","4xumA-2qmmA:23.64"],["5O96_B_SAMB501_0","RIBOSOMAL RNA SMALL SUBUNIT METHYLTRANSFERASE E","2qmm","UPF0217 PROTEIN AF_1056","Archaeoglobus fulgidus",6,"LEU A 221;ILE A 241;GLY A 242;GLY A 246;LEU A 265;LEU A 270","SAM A 301 (-4.3A);SAM A 301 ( 4.8A);SAM A 301 (-3.6A);SAM A 301 (-3.3A);SAM A 301 (-4.4A);SAM A 301 (-4.5A)","0.73A","5o96A-2qmmA:10.9;5o96B-2qmmA:11.2","5o96A-2qmmA:25.40;5o96B-2qmmA:25.40"],["5O96_G_SAMG501_0","RIBOSOMAL RNA SMALL SUBUNIT METHYLTRANSFERASE E","2qmm","UPF0217 PROTEIN AF_1056","Archaeoglobus fulgidus",5,"LEU A 221;GLY A 242;GLY A 246;LEU A 265;GLU A 273","SAM A 301 (-4.3A);SAM A 301 (-3.6A);SAM A 301 (-3.3A);SAM A 301 (-4.4A);None","0.77A","5o96G-2qmmA:11.2","5o96G-2qmmA:25.40"],["5O96_G_SAMG501_0","RIBOSOMAL RNA SMALL SUBUNIT METHYLTRANSFERASE E","2qmm","UPF0217 PROTEIN AF_1056","Archaeoglobus fulgidus",5,"LEU A 221;GLY A 242;GLY A 246;SER A 264;LEU A 265","SAM A 301 (-4.3A);SAM A 301 (-3.6A);SAM A 301 (-3.3A);SAM A 301 (-3.4A);SAM A 301 (-4.4A)","1.03A","5o96G-2qmmA:11.2","5o96G-2qmmA:25.40"],["5TWJ_A_SAMA201_0","RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE H","2qmm","UPF0217 PROTEIN AF_1056","Archaeoglobus fulgidus",7,"LEU A 221;ILE A 241;GLY A 242;GLY A 246;SER A 264;LEU A 265;SER A 266","SAM A 301 (-4.3A);SAM A 301 ( 4.8A);SAM A 301 (-3.6A);SAM A 301 (-3.3A);SAM A 301 (-3.4A);SAM A 301 (-4.4A);SAM A 301 (-4.2A)","0.61A","5twjA-2qmmA:6.6","5twjA-2qmmA:25.24"],["5TWJ_A_SAMA201_0","RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE H","2qmm","UPF0217 PROTEIN AF_1056","Archaeoglobus fulgidus",7,"LEU A 221;ILE A 241;GLY A 242;GLY A 246;SER A 264;SER A 266;LEU A 270","SAM A 301 (-4.3A);SAM A 301 ( 4.8A);SAM A 301 (-3.6A);SAM A 301 (-3.3A);SAM A 301 (-3.4A);SAM A 301 (-4.2A);SAM A 301 (-4.5A)","0.46A","5twjA-2qmmA:6.6","5twjA-2qmmA:25.24"],["5TWJ_B_SAMB201_0","RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE H","2qmm","UPF0217 PROTEIN AF_1056","Archaeoglobus fulgidus",6,"LEU A 221;ILE A 241;GLY A 242;GLY A 246;LEU A 265;SER A 266","SAM A 301 (-4.3A);SAM A 301 ( 4.8A);SAM A 301 (-3.6A);SAM A 301 (-3.3A);SAM A 301 (-4.4A);SAM A 301 (-4.2A)","0.66A","5twjB-2qmmA:6.4","5twjB-2qmmA:25.24"],["5TWJ_B_SAMB201_0","RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE H","2qmm","UPF0217 PROTEIN AF_1056","Archaeoglobus fulgidus",6,"LEU A 221;ILE A 241;GLY A 242;GLY A 246;SER A 266;LEU A 270","SAM A 301 (-4.3A);SAM A 301 ( 4.8A);SAM A 301 (-3.6A);SAM A 301 (-3.3A);SAM A 301 (-4.2A);SAM A 301 (-4.5A)","0.50A","5twjB-2qmmA:6.4","5twjB-2qmmA:25.24"],["5TWJ_C_SAMC201_0","RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE H","2qmm","UPF0217 PROTEIN AF_1056","Archaeoglobus fulgidus",6,"LEU A 221;ILE A 241;GLY A 242;SER A 264;LEU A 265;SER A 266","SAM A 301 (-4.3A);SAM A 301 ( 4.8A);SAM A 301 (-3.6A);SAM A 301 (-3.4A);SAM A 301 (-4.4A);SAM A 301 (-4.2A)","0.56A","5twjC-2qmmA:7.4","5twjC-2qmmA:25.24"],["5TWJ_C_SAMC201_0","RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE H","2qmm","UPF0217 PROTEIN AF_1056","Archaeoglobus fulgidus",6,"LEU A 221;ILE A 241;GLY A 242;SER A 264;SER A 266;LEU A 270","SAM A 301 (-4.3A);SAM A 301 ( 4.8A);SAM A 301 (-3.6A);SAM A 301 (-3.4A);SAM A 301 (-4.2A);SAM A 301 (-4.5A)","0.46A","5twjC-2qmmA:7.4","5twjC-2qmmA:25.24"],["5TWJ_D_SAMD201_0","RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE H","2qmm","UPF0217 PROTEIN AF_1056","Archaeoglobus fulgidus",7,"LEU A 221;ILE A 241;GLY A 242;GLY A 246;LEU A 265;SER A 266;LEU A 270","SAM A 301 (-4.3A);SAM A 301 ( 4.8A);SAM A 301 (-3.6A);SAM A 301 (-3.3A);SAM A 301 (-4.4A);SAM A 301 (-4.2A);SAM A 301 (-4.5A)","0.66A","5twjD-2qmmA:7.4","5twjD-2qmmA:25.24"],["5ZHM_B_SAMB301_1","TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE","2qmm","UPF0217 PROTEIN AF_1056","Archaeoglobus fulgidus",5,"LEU A 221;GLY A 242;GLY A 246;SER A 264;LEU A 270","SAM A 301 (-4.3A);SAM A 301 (-3.6A);SAM A 301 (-3.3A);SAM A 301 (-3.4A);SAM A 301 (-4.5A)","0.78A","5zhmB-2qmmA:8.4","5zhmB-2qmmA:23.00"]]